TRVLX
Price
$53.60
Change
+$0.45 (+0.85%)
Updated
Jun 2 closing price
Net Assets
33.31B
VIVIX
Price
$83.17
Change
+$0.71 (+0.86%)
Updated
Jun 2 closing price
Net Assets
237.83B
Interact to see
Advertisement

TRVLX vs VIVIX

Header iconTRVLX vs VIVIX Comparison
Open Charts TRVLX vs VIVIXBanner chart's image
TRVLX vs VIVIX Comparison Chart in %
View a ticker or compare two or three
VS
TRVLX vs. VIVIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TRVLX is a StrongBuy and VIVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 238B vs. TRVLX (33.3B). VIVIX pays higher dividends than TRVLX: VIVIX (1.87) vs TRVLX (0.82). TRVLX was incepted earlier than VIVIX: TRVLX (32 years) vs VIVIX (28 years). TRVLX (0.72) is less costly to investors than VIVIX (0.03). TRVLX is a more actively managed with annual turnover of: 59.50 vs. VIVIX (8.00). TRVLX has a lower initial minimum investment than VIVIX: TRVLX (2500) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 23.69 vs. TRVLX (15.72). VIVIX return over 5 years is better than : 51.51 vs. TRVLX (13.88).
TRVLXVIVIXTRVLX / VIVIX
Total Expense Ratio0.710.032,367%
Annual Report Gross Expense Ratio0.720.032,400%
Fund Existence32 years28 years-
Gain YTD11.10011.62395%
Front LoadN/AN/A-
Min. Initial Investment250050000000%
Min. Initial Investment IRAN/AN/A-
Net Assets33.3B238B14%
Annual Yield % from dividends0.821.8744%
Returns for 1 year15.7223.6966%
Returns for 3 years41.4754.5076%
Returns for 5 years13.8851.5127%
Returns for 10 years84.16152.5855%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SBACX31.24N/A
N/A
Touchstone Balanced C
COFYX44.14N/A
N/A
Columbia Contrarian Core Inst3
SPSAX21.97N/A
N/A
Sterling Capital Behav Sm Cp Val Eq A
EMEAX19.39N/A
N/A
Ashmore Emerging Markets Equity A
BMSLX16.74N/A
N/A
MFS Blended Research Mid Cap Eq I